{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:06:54Z","timestamp":1791094014390,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.3816\/clm.2009.s.015","type":"journal-article","created":{"date-parts":[[2009,9,29]],"date-time":"2009-09-29T10:04:58Z","timestamp":1254218698000},"page":"S214-S221","source":"Crossref","is-referenced-by-count":68,"special_numbering":"S3","title":["T-Cell Lymphoblastic Lymphoma and T-Cell Acute Lymphoblastic Leukemia: A Separate Entity?"],"prefix":"10.3816","volume":"9","author":[{"given":"Dieter","family":"Hoelzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"G\u00f6kbuget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2009.s.015_bib1","series-title":"WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues","first-page":"265","author":"Swerdlow","year":"2008"},{"key":"10.3816\/CLM.2009.s.015_bib2","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","article-title":"Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995","volume":"92","author":"Groves","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CLM.2009.s.015_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/pbc.20550","article-title":"Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma","volume":"47","author":"Raetz","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.3816\/CLM.2009.s.015_bib4","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1080\/10428190701509772","article-title":"Is there a difference in childhood T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma?","volume":"48","author":"Uyttebroeck","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2009.s.015_bib5","first-page":"416","article-title":"Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM Group report","volume":"95","author":"Reiter","year":"2000","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.015_bib6","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1182\/blood-2002-01-0110","article-title":"Outcome of adult patients with Tlymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia","volume":"99","author":"Hoelzer","year":"2002","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.015_bib7","first-page":"118","article-title":"A novel approach for minimal residual disease detection in childhood T-Cell lymphoblastic lLymphoma (T-LL): A Children'S Oncology Group Report","author":"Coustan-Smith","year":"2007","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.015_bib8","series-title":"Acute Leukemias","first-page":"167","article-title":"Treatment of adult ALL according to the protocols of the German Multicenter Study Group for Adult ALL","author":"G\u00f6kbuget","year":"2008"},{"key":"10.3816\/CLM.2009.s.015_bib9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1182\/blood.V57.4.679.679","article-title":"Lymphoblastic lymphoma in adults: results of a pilot protocol","volume":"57","author":"Coleman","year":"1981","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.015_bib10","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1200\/JCO.1986.4.11.1628","article-title":"Treatment of lymphoblastic lymphoma in adults","volume":"4","author":"Coleman","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.s.015_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/10428199409049726","article-title":"Long-term follow-up of a CHOPbased regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma","volume":"15","author":"Colgan","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2009.s.015_bib12","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s002770100363","article-title":"Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients","volume":"80","author":"Chen","year":"2001","journal-title":"Ann Hematol"},{"key":"10.3816\/CLM.2009.s.015_bib13","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.1992.10.7.1078","article-title":"Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients","volume":"10","author":"Morel","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.s.015_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1182\/blood.V61.1.92.92","article-title":"Successful therapy of convoluted T-lymphoblastic lymphoma in the adult","volume":"61","author":"Levine","year":"1983","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.3816\/CLM.2009.s.015_bib15","first-page":"106","article-title":"Lymphoblastic lymphoma (LBL) and acute lymphoblastic leukaemia (ALL) in adults: relationships and therapeutic perspectives","volume":"4","author":"Santini","year":"1989","journal-title":"Bone Marrow Transplant"},{"key":"10.3816\/CLM.2009.s.015_bib16","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/sj.leu.2404156","article-title":"High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)","volume":"20","author":"Jabbour","year":"2006","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2009.s.015_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1200\/JCO.1986.4.1.57","article-title":"Lymphoblastic lymphoma in adults","volume":"4","author":"Slater","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.s.015_bib18","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1182\/blood-2003-12-4428","article-title":"Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma","volume":"104","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.015_bib19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/annonc\/mdl426","article-title":"Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes","volume":"18","author":"Song","year":"2007","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2009.s.015_bib20","first-page":"1088","volume":"84","author":"Bassan","year":"1999","journal-title":"Haematologica"},{"key":"10.3816\/CLM.2009.s.015_bib21","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/bjc.1995.405","article-title":"Childhood T-cell lymphoblastic lymphoma\u2013 does early resolution of mediastinal mass predict for final outcome? The United Kingdom Children's Cancer Study Group (UKCCSG)","volume":"72","author":"Shepherd","year":"1995","journal-title":"Br J Cancer"},{"key":"10.3816\/CLM.2009.s.015_bib22","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/0277-5379(88)90053-3","article-title":"Lymphoblastic lymphoma in adults: a clinicopathological study of 34 cases treated at the Institut Gustave-Roussy","volume":"24","author":"Salloum","year":"1988","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.3816\/CLM.2009.s.015_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2005-04-1754","article-title":"Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol","volume":"107","author":"Vitale","year":"2006","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.015_bib24","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1182\/blood-2004-09-3666","article-title":"Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study","volume":"105","author":"Asnafi","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.015_bib25","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1200\/JCO.2007.11.5253","article-title":"Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable Outcome","volume":"25","author":"Baldus","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.s.015_bib26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrc1880","article-title":"Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia","volume":"6","author":"Grabher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.3816\/CLM.2009.s.015_bib27","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/sj.leu.2404603","article-title":"Why and how to quantify minimal residual disease in acute lymphoblastic leukemia?","volume":"21","author":"Szczepanski","year":"2007","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2009.s.015_bib28","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1182\/blood-2005-07-2708","article-title":"Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia","volume":"107","author":"Br\u00fcggemann","year":"2006","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.015_bib29","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1182\/blood-2006-07-037093","article-title":"Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after main-tenance treatment: data from the GMALL 06\/99 and 07\/03 trials","volume":"109","author":"Raff","year":"2007","journal-title":"Blood"},{"issue":"suppl 1","key":"10.3816\/CLM.2009.s.015_bib30","first-page":"S129","article-title":"Risk\/MRD adapted GMALL trials in adult ALL","volume":"83","author":"G\u00f6kbuget","year":"2004","journal-title":"Ann Hematol"},{"key":"10.3816\/CLM.2009.s.015_bib31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2141.1989.tb00224.x","article-title":"Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission","volume":"73","author":"Milpied","year":"1989","journal-title":"Br J Haematol"},{"issue":"suppl 1","key":"10.3816\/CLM.2009.s.015_bib32","first-page":"42","article-title":"Autologous bone marrow transplantation for adult advanced stage lymphoblastic lymphoma in first CR. A study of the NHLCSG","volume":"5","author":"Santini","year":"1991","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2009.s.015_bib33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/10428199609054867","article-title":"Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients","volume":"23","author":"Zinzani","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2009.s.015_bib34","first-page":"33","article-title":"Autologous bone marrow transplantation in 22 adult patients with lymphoblastic lymphoma responsive to conventional dose chemotherapy","volume":"10","author":"Baro","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.3816\/CLM.2009.s.015_bib35","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1200\/JCO.1992.10.4.644","article-title":"Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission","volume":"10","author":"Verdonck","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.s.015_bib36","first-page":"2130a","article-title":"Autologous stem cell transplantation (ASCT) for lymphoblastic lymphoma (LBL)","volume":"94","author":"Conde","year":"1999","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.015_bib37","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1200\/JCO.2001.19.11.2927","volume":"19","author":"Sweetenham","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.s.015_bib38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1023\/A:1008202808144","article-title":"Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center","volume":"9","author":"Bouabdallah","year":"1998","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2009.s.015_bib39","first-page":"1121a","article-title":"Allogeneic transplantation for lymphoma produces a lower relapse rate than autologous transplantation but survival is worse because of higher treatment related mortality -A report of 764 cases from the EBMT lymphoma registry","volume":"90","author":"Peniket","year":"1997","journal-title":"Blood"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011703432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011703432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T15:47:10Z","timestamp":1590162430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011703432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":39,"alternative-id":["S1557919011703432"],"URL":"https:\/\/doi.org\/10.3816\/clm.2009.s.015","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}